Geode Capital Management
MDNA

Geode Capital Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Geode Capital Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34,144
Closed -$9.76K – 4777
2023
Q3 		$9.76K Hold
34,144
– – ﹤0.01% 4729
2023
Q2 		$16.4K Hold
34,144
– – ﹤0.01% 4679
2023
Q1 		$22.2K Hold
34,144
– – ﹤0.01% 4686
2022
Q4 		$16K Hold
34,144
– – ﹤0.01% 4795
2022
Q3 		$28K Hold
34,144
– – ﹤0.01% 4861
2022
Q2 		$39K Hold
34,144
– – ﹤0.01% 4827
2022
Q1 		$43K Buy
34,144
+6,511
+24% +$10.1K ﹤0.01% 4836
2021
Q4 		$45K Hold
27,633
– – ﹤0.01% 4877
2021
Q3 		$76K Buy
27,633
+5,197
+23% +$12.9K ﹤0.01% 4721
2021
Q2 		$67K Buy
22,436
+2,674
+14% +$9.89K ﹤0.01% 4624
2021
Q1 		$80K Buy
+19,762
New +$80.5K ﹤0.01% 4338

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Geode Capital Management's MDNA Position: Q4 2023 in Review

Geode Capital Management sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 34,144 shares — an estimated $9.76K sold.

Geode Capital Management first reported a position in MDNA in Q1 2021 and held it in 11 quarters. The position peaked at $80K in Q1 2021. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Geode Capital Management reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 34,144 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $9.76K.
  • Geode Capital Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q1 2021 and held it in 11 quarters.
  • Geode Capital Management's Medicenna Therapeutics Corp. Common Shares position peaked at $80K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.